- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03873753
Relationship Between Oral Hygiene in Newborns and Candida Spp.
March 12, 2019 updated by: Jose Carlos P Imparato, Faculty Sao Leopoldo Mandic Campinas
Relationship Between Oral Hygiene in Newborns and Candida Spp.: A Randomized Clinical Trial
Little is known regarding the effectiveness of neonatal oral hygiene and its relationship to colonization by Candida spp. in edentulous oral cavities.
Thus, the objective of this study is to evaluate whether the oral hygiene of edentulous infants favors colonization by Candida spp.
Newborns with up to 48 hours of life will randomly allocated to two groups.
The mothers will instructed to clean the oral cavity with gauze and mineral water three times a day, in the test group, and not to clean, in the control group.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
276
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sao Paulo
-
Campinas, Sao Paulo, Brazil, 13045755
- Recruiting
- Faculty Sao Leopoldo Mandic
-
Contact:
- Jose Carlos P Imparato, PhD
- Phone Number: +551935183601
- Email: jimparato@usp.br
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 2 days (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- A signed statement of informed consent
- Newborns up to 48 hours of life
- Exclusive breastfeeding
- Edentulous oral cavity
Exclusion Criteria:
- Any feeding other than breastfeeding
- Use of pacifier
- Digit sucking
- Systemic alterations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Oral cleaning
The oral cavity will be clean with gauze and mineral water three times a day.
|
Gauze and mineral water
|
Active Comparator: No oral cleaning
The oral cavity will not be cleaned.
|
Absence of cleaning
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from number of Candida spp CFU/mm3
Time Frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
Non-stimulated saliva will be collected with the aid of a sterile swab (Absorve®) from all infants.
The samples were incubated at 37°C and analyzed after 48 hours to quantify the colony forming units (CFU/mm3)
|
At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean of patient's birth weight in the test group as assessed by questionnaire
Time Frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
Number of males in the test group as assessed by questionnaire
Time Frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
Number of cesarean delivery in the test group as assessed by questionnaire
Time Frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
Mean of patient's gestational week in the test group as assessed by questionnaire
Time Frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
Mean of patient's birth length in the test group as assessed by questionnaire
Time Frame: At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jose Carlos P Imparato, PhD, Faculdade Sao Leopoldo Mandic, Campinas, SP, Brazil
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 2, 2017
Primary Completion (Anticipated)
July 31, 2020
Study Completion (Anticipated)
December 30, 2020
Study Registration Dates
First Submitted
February 21, 2019
First Submitted That Met QC Criteria
March 12, 2019
First Posted (Actual)
March 13, 2019
Study Record Updates
Last Update Posted (Actual)
March 13, 2019
Last Update Submitted That Met QC Criteria
March 12, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SLM 6
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Candidiasis, Oral
-
Summa Health SystemCompletedOral CandidiasisUnited States
-
University of Santiago de CompostelaNot yet recruitingMicrobial Colonization | Oral Candidiasis | Xerostomia | Radiotherapy; Complications | Candida Albicans Infection | Oral Candidiasis RecurrentSpain
-
Raphael Freitas de SouzaFundação de Amparo à Pesquisa do Estado de São PauloCompletedOral Hygiene | Dental Plaque | Oral Candidiasis | Denture StomatitisBrazil
-
Raphael Freitas de SouzaCompletedOral Hygiene | Dental Plaque | Oral Candidiasis | Denture StomatitisBrazil
-
University of FloridaTerminatedHIV Infections | CandidiasisUnited States
-
Hadassah Medical OrganizationCompletedOral Candidiasis | Denture StomatitisIsrael
-
Hams Hamed AbdelrahmanActive, not recruiting
-
Yasmine gamilCompleted
-
Federal University of the Valleys of Jequitinhonha...UnknownOral Hygiene | Candidiasis, Oral | Behavior | NewbornsBrazil
-
University of BelgradeRecruiting
Clinical Trials on Cleaning
-
Malmö UniversityLund UniversityCompletedPulmonary Disease, Chronic Obstructive | Dental Plaque | COPD ExacerbationSweden
-
University of Maryland, BaltimoreCompletedInfection ControlUnited States
-
Massachusetts General HospitalWest Virginia University; endOclear, LLC.CompletedAirway Obstruction | Pneumonia, Ventilator-Associated | Endotracheal Extubation | Airway Control | Breathing MechanicsUnited States
-
Medtronic - MITGTerminated
-
University of LisbonNot yet recruiting
-
Minimally Invasive Devices, Inc.CompletedLaparoscopic SurgeryUnited States
-
Cardiff and Vale University Health BoardCompletedGingivitis | Dental PlaqueUnited Kingdom
-
University of MichiganNational Institute on Aging (NIA)WithdrawnCovid19 | SARS-CoV Infection
-
Massachusetts General HospitalBrigham and Women's Hospital; Rhode Island HospitalCompletedCritically Ill | Ventilator Associated PneumoniaUnited States